SL
RGEN icon

Summitry LLC’s Repligen RGEN Stock Holding History

Summitry LLC’s Portfolio RGEN Stock Details RGEN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$373K Buy
2,737
+352
+15% +$43.2K 0.01% 204
2026
Q1 		$281K Buy
2,385
+644
+37% +$90K 0.01% 221
2025
Q4 		$285K Buy
1,741
+244
+16% +$38.2K 0.01% 188
2025
Q3 		$200K Buy
+1,497
New +$182K 0.01% 215

Other funds holding RGEN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
UCFA
United Capital Financial Advisors Irving, Texas $18.2B AUM 22.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
MC
Maverick Capital Dallas, Texas $11.3B AUM 76.6% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

Summitry LLC's RGEN Position: Q2 2026 in Review

Summitry LLC increased its Repligen (RGEN) stake by 15% in Q2 2026, buying an estimated $43.2K and bringing the position to 2,737 shares worth $373K. The position accounts for 0.01% of the portfolio, ranked #204.

Summitry LLC first reported a position in RGEN in Q3 2025 and has held it in 4 quarters since. 482 funds tracked by Wall St. Rank hold RGEN as of Q2 2026.

  • Summitry LLC held 2,737 shares of Repligen worth $373K as of Q2 2026.
  • Summitry LLC bought 352 Repligen shares in Q2 2026, an estimated $43.2K.
  • Repligen made up 0.01% of Summitry LLC's portfolio in Q2 2026, its #204 holding.
  • Summitry LLC first reported a position in Repligen in Q3 2025 and has held it in 4 quarters since.
  • 482 funds tracked by Wall St. Rank held Repligen as of Q2 2026.

Based on Summitry LLC's 13F filing for Q2 2026, filed 21 Jul 2026.